More about

Urinary Tract Infections

News
February 28, 2025
2 min read
Save

Infections requiring hospitalization linked to elevated heart failure risk

Infections requiring hospitalization linked to elevated heart failure risk

Infections requiring hospitalization were associated with increased risk for future incident heart failure, regardless of infection and HF subtype, according to new data published in the Journal of the American Heart Association.

News
December 19, 2024
1 min read
Save

Top in women’s health: UTI diagnosis, treatment; satisfaction with permanent contraception

Top in women’s health: UTI diagnosis, treatment; satisfaction with permanent contraception

Healio spoke with Cynthia Fok, MD, associate professor in the department of urology at the University of Minnesota Medical School, about the prevalence of urinary tract infections in U.S. women and the current treatments available.

News
December 10, 2024
5 min read
Save

Q&A: Ensuring proper diagnosis, being ‘good antibiotic stewards’ key to UTI treatment

Q&A: Ensuring proper diagnosis, being ‘good antibiotic stewards’ key to UTI treatment

Antibiotics remain the most common way to treat urinary tract infections, yet many women remain untreated because the condition is often overlooked or they do not receive appropriate testing and care.

News
April 25, 2024
1 min read
Save

FDA approves pivmecillinam tablets to treat urinary tract infections for women

FDA approves pivmecillinam tablets to treat urinary tract infections for women

The FDA approved pivmecillinam tablets to treat uncomplicated urinary tract infections caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus for women, according to an agency press release.

News
January 16, 2024
2 min read
Save

FDA approves Keytruda-based combination for advanced cervical cancer

FDA approves Keytruda-based combination for advanced cervical cancer

The FDA approved pembrolizumab in combination with chemoradiotherapy for the treatment of certain women with stage III to stage IVA cervical cancer.

News
January 28, 2023
2 min read
Save

Discordant outcomes at cUTI test-of-cure visit associated with risk of clinical failure

Discordant outcomes at cUTI test-of-cure visit associated with risk of clinical failure

An analysis of phase 3 trials of patients with complicated UTIs found that having discordant outcomes at a test-of-cure visit — clinical success but microbiological failure — was associated with an increased risk for late clinical failure.